Cell Signaling Technology

Phospho-5-Lipoxygenase (Ser271) Antibody

#3748 · $362

100
Citing papers
13.1k
Combined citations
Supplier page Find this product

Research areas

Extracellular vesicles in disease17MicroRNA in disease regulation16Cell Adhesion Molecules Research10PI3K/AKT/mTOR signaling in cancer9Cancer-related molecular mechanisms research8Chronic Lymphocytic Leukemia Research6Cancer, Hypoxia, and Metabolism5Alzheimer's disease research and treatments5

Papers citing this product

1
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Blood·2011·791 cit.·DOI
2
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Nature Communications·2019·516 cit.·DOI
3
Human Umbilical Cord Mesenchymal Stem Cell Exosomes Enhance Angiogenesis Through the Wnt4/β-Catenin Pathway
Stem Cells Translational Medicine·2015·467 cit.·DOI
4
Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1
Molecular Cancer·2017·402 cit.·DOI
5
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
International Journal of Oncology·2015·363 cit.·DOI
6
Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity
Cell Discovery·2016·303 cit.·DOI
7
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
Blood·2005·300 cit.·DOI
8
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
Nature Communications·2017·278 cit.·DOI
9
Direct and Potent Regulation of γ-Secretase by Its Lipid Microenvironment
Journal of Biological Chemistry·2008·266 cit.·DOI
10
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
The EMBO Journal·2011·262 cit.·DOI